Blanchable erythematic coalescing papules-very concentrated on her upper torso, arms and mid cheeks with accompanying warmth; Developed mild to moderate nausea; Lost her appetite; Watery diarrhea; Tremors; Lightheadedness; Erythema on her upper arms which subsequently spread to her face/torso/upper legs; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of DECREASED APPETITE (Lost her appetite), DIARRHOEA (Watery diarrhea), TREMOR (Tremors), DIZZINESS (Lightheadedness) and ERYTHEMA (Erythema on her upper arms which subsequently spread to her face/torso/upper legs) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Type 2 diabetes mellitus (Controlled), Hyperlipidemia, Arthritis, Hypertension and Tuberculosis gastrointestinal (Not infections, not on isolation). Concomitant products included VITAMIN B6, IZONIAZID from 26-Feb-2021 to an unknown date, RIFABUTIN from 26-Feb-2021 to an unknown date, PYRAZINAMIDE from 26-Feb-2021 to an unknown date, ETHAMBUTOL from 26-Feb-2021 to an unknown date, HYDROXYZINE, SERTRALINE from 26-Feb-2021 to an unknown date, VITAMIN B COMPLEX (B COMPLEX [VITAMIN B COMPLEX]) from 26-Feb-2021 to an unknown date, CELECOXIB from 26-Feb-2021 to an unknown date, METFORMIN from 26-Feb-2021 to an unknown date, ACETYLSALICYLIC ACID (ASPIRIN 81) from 26-Feb-2021 to an unknown date, ATORVASTATIN from 26-Feb-2021 to an unknown date, FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) from 26-Feb-2021 to an unknown date, DICLOFENAC from 26-Feb-2021 to an unknown date, CALCIUM, COLECALCIFEROL (OYSTER SHELL CALCIUM + D3) from 26-Feb-2021 to an unknown date, GABAPENTIN from 26-Feb-2021 to an unknown date and CYCLOBENZAPRINE from 26-Feb-2021 to an unknown date for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced DECREASED APPETITE (Lost her appetite), DIARRHOEA (Watery diarrhea), TREMOR (Tremors), DIZZINESS (Lightheadedness), ERYTHEMA (Erythema on her upper arms which subsequently spread to her face/torso/upper legs) and NAUSEA (Developed mild to moderate nausea). On 09-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Blanchable erythematic coalescing papules-very concentrated on her upper torso, arms and mid cheeks with accompanying warmth). At the time of the report, DECREASED APPETITE (Lost her appetite), DIARRHOEA (Watery diarrhea), TREMOR (Tremors), DIZZINESS (Lightheadedness) and NAUSEA (Developed mild to moderate nausea) outcome was unknown and ERYTHEMA (Erythema on her upper arms which subsequently spread to her face/torso/upper legs) and RASH ERYTHEMATOUS (Blanchable erythematic coalescing papules-very concentrated on her upper torso, arms and mid cheeks with accompanying warmth) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patients CMP  and blood investigations are still yet pending and HCP advice not to take second vaccine also said to be on hold.